Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 18831696.
- Also identified by DOI 10.1086/592302.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- Intracranial Hemorrhages
- Pyridines
- Pyrones